Table 3 Postoperative treatment management
From: Cardiac surgery under cardiopulmonary bypass in pregnancy: report of four cases
Patient no | Fetus protection treatment | Postoperative fetal monitoring | Duration of fetal monitoring | Anti-infective drugs | Duration of anti-infective treatment | Maternal and fetal outcomes |
|---|---|---|---|---|---|---|
1 | Atosiban, magnesium sulfate | FHR was monitored by Doppler ultrasound, closely prenatal examination | Until the time of labor | Vancomycin, imipenem | 6Â weeks after surgery | Alive, preterm birth |
2 | Atosiban, magnesium sulfate | FHR was monitored by Doppler ultrasound, closely prenatal examination | Until the time of labor | Vancomycin, meropenem | 6Â weeks after surgery | Alive, term birth |
3 | – | – | – | – | – | Alive, preterm birth |
4 | – | – | – | vancomycin, meropenem | 6 weeks after surgery | Alive, preterm birth |